1. Home
  2. XNCR vs PBI Comparison

XNCR vs PBI Comparison

Compare XNCR & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$29.82

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Pitney Bowes Inc.

PBI

Pitney Bowes Inc.

N/A

Current Price

$16.34

Market Cap

2.3B

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
XNCR
PBI
Founded
1997
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
XNCR
PBI
Price
$29.82
$16.34
Analyst Decision
Buy
Hold
Analyst Count
14
5
Target Price
★ $41.58
$19.72
AVG Volume (30 Days)
★ 1.5M
1.4M
Earning Date
11-13-2026
10-28-2026
Dividend Yield
N/A
★ 2.43%
EPS Growth
65.36
★ 175.00
EPS
N/A
★ 1.12
Revenue
$125,576,000.00
★ $1,892,629,000.00
Revenue This Year
$18.52
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$21.96
Revenue Growth
★ 13.65
N/A
52 Week Low
$10.38
$8.95
52 Week High
$33.60
$19.07

Technical Indicators

Market Signals
Indicator
XNCR
PBI
Relative Strength Index (RSI) 65.50 38.19
Support Level $22.80 $15.89
Resistance Level $30.61 $16.56
Average True Range (ATR) 1.71 0.48
MACD 0.59 -0.07
Stochastic Oscillator 61.74 17.99

Price Performance

Historical Comparison
XNCR
PBI

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.

Share on Social Networks: